The above findings further suggest that the Pep_A6 vaccine may modulate PPARα to downregulate the expression of lipid metabolism-related genes, thereby effectively reducing the level of LDL-C in mouse serum, inhibiting liver lipid accumulation, and preventing atherosclerosis. The gene discussed is PPARA; the disease is atherosclerosis.